Collin A Melton

Title: Collin A Melton: Innovator in Cancer Classification Technologies

Introduction

Collin A Melton is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of data classification, particularly in the context of cancer diagnosis. With a total of 3 patents to his name, Melton's work is at the forefront of integrating technology with healthcare.

Latest Patents

One of Melton's latest patents focuses on convolutional neural network systems and methods for data classification. This innovation provides a framework for classifying cancer conditions across various types. The process involves obtaining cancer conditions and genotypic data constructs for multiple training subjects. These constructs are then formatted into vector sets, which are input into a network architecture that includes a convolutional neural network. The architecture is designed to adjust filter weights based on the comparison of scores obtained from the input data, thereby enhancing the network's ability to classify cancer conditions accurately.

Career Highlights

Throughout his career, Melton has worked with notable companies such as Grail, Inc. and Emerald Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer classification technologies.

Collaborations

Some of Melton's coworkers include Virgil Nicula and Anton Valouev. Their collaborative efforts have contributed to the advancement of technologies in the healthcare sector.

Conclusion

Collin A Melton is a key figure in the development of innovative technologies for cancer classification. His patents and career achievements reflect his commitment to improving healthcare through advanced data classification methods.